Literature DB >> 11846839

TNF-alpha is expressed at sites of parasite and tissue destruction in the spleen of mice acutely infected with Trypanosoma cruzi.

E S Lima1, Z A Andrade, S G Andrade.   

Abstract

Mice infected with a macrophagotropic strain of Trypanosoma cruzi develop progressive splenomegaly due to reactive hyperplasia with increased number of lymphocytes and macrophages, culminating in parasite disintegration and necrosis of parasitized cells. Necrotic changes have been attributed to the liberation of toxic cytokines, including TNF-alpha, from parasitized macrophages. In the present study, the presence of TNF-alpha was investigated in situ. In addition the participation of destroyed parasites in inducing the liberation of TNF-alpha was examined in two highly susceptible mice strains (C3H and Swiss) and a more resistant strain (DBA). Swiss (90) C3H/He (83) and DBA (30) mice were infected with the Peruvian strain of T. cruzi. Nineteen infected Swiss mice, and 22 infected C3H/He were treated with Benznidazole (one or two doses, 100 mg/kg bw/day), on the 8th and 9th days after infection. Necrotic splenic lesions occurred in both susceptible and resistant strains of mice. Although differing in degree, lesions were more intense in C3H and Swiss than in DBA mice. Comparing untreated and treated susceptible mice, necrotic lesions were significantly less intense in the latter. By specific monoclonal antibody immunolabelling, TNF-alpha was demonstrated in the cytoplasm of macrophages and within necrotic areas, from Swiss, C3H/He and DBA mouse spleens. In conclusion, TNF-alpha, probably synthesized by macrophages, was strongly expressed at the sites of parasite and cell destruction, thus appearing to play a pivotal role in splenic necrotic changes associated with severe experimental T. cruzi infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11846839      PMCID: PMC2517787          DOI: 10.1046/j.1365-2613.2001.00203.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  20 in total

1.  Polyclonal lymphocyte responses to murine Trypanosoma cruzi infection. I. Quantitation of both T- and B-cell responses.

Authors:  P M Minoprio; H Eisen; L Forni; M R D'Imperio Lima; M Joskowicz; A Coutinho
Journal:  Scand J Immunol       Date:  1986-12       Impact factor: 3.487

2.  Benznidazole, a drug employed in the treatment of Chagas' disease, down-regulates the synthesis of nitrite and cytokines by murine stimulated macrophages.

Authors:  S Revelli; C Le Page; E Piaggio; J Wietzerbin; O Bottasso
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

3.  Immunosuppression in mice infected with Trypanosoma cruzi (Chagas, 1909). II--Trypomastigote crude extract (TCE) suppress the humoral immune response in mice.

Authors:  A C Corsini; M G Costa
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1981 May-Jun       Impact factor: 1.846

4.  Immunosuppression in mice infected with Trypanosoma cruzi (Chagas, 1909). I--Evidences of polyclonal B cell activation in experimental infections mimicked by an extract prepared from circulating trypomastigotes.

Authors:  A C Corsini; M G Costa
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1981 May-Jun       Impact factor: 1.846

5.  Is TNF alpha involved in early susceptibility of Trypanosoma cruzi-infected C3H/He mice?

Authors:  N Starobinas; M Russo; P Minoprio; M Hontebeyrie-Joskowicz
Journal:  Res Immunol       Date:  1991-02

6.  Tumour necrosis factor (cachectin) production during experimental Chagas' disease.

Authors:  R L Tarleton
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

7.  Patterns of resistance of inbred mice to Trypanosoma cruzi are determined by parasite strain.

Authors:  V Andrade; M Barral-Netto; S G Andrade
Journal:  Braz J Med Biol Res       Date:  1985       Impact factor: 2.590

8.  Immunological response of Swiss mice to infection with three different strains of Trypanosoma cruzi.

Authors:  S G Andrade; V Andrade; C Brodskyn; J B Magalhães; M B Netto
Journal:  Ann Trop Med Parasitol       Date:  1985-08

9.  [Immunological aspects of infection of 6 inbred strains of mice by 3 different strains of Trypanosoma cruzi].

Authors:  V Andrade; M Barral-Netto; S G Andrade; J B Magalhães
Journal:  Mem Inst Oswaldo Cruz       Date:  1985 Apr-Jun       Impact factor: 2.743

10.  Morphological, cytochemical, functional, and proliferative characteristics of four murine macrophage-like cell lines.

Authors:  R van Furth; M van Schadewijk-Nieuwstad; I Elzenga-Claasen; C Cornelisse; P Nibbering
Journal:  Cell Immunol       Date:  1985-02       Impact factor: 4.868

View more
  9 in total

1.  Increased association of Trypanosoma cruzi with sialoadhesin positive mice macrophages.

Authors:  Verônica G Monteiro; Caroliny S S Lobato; Alexandre R Silva; Diego V Medina; Marco A de Oliveira; Sergio H Seabra; Wanderley de Souza; Renato A DaMatta
Journal:  Parasitol Res       Date:  2005-09-07       Impact factor: 2.289

2.  Role of NO synthase in the development of Trypanosoma cruzi-induced cardiomyopathy in mice.

Authors:  Jorge L Durand; Shankar Mukherjee; Fernando Commodari; Andrea P De Souza; Dazhi Zhao; Fabiana S Machado; Herbert B Tanowitz; Linda A Jelicks
Journal:  Am J Trop Med Hyg       Date:  2009-05       Impact factor: 2.345

3.  Domestic Pig (Sus scrofa) as an Animal Model for Experimental Trypanosoma cruzi Infection.

Authors:  Verónica Yauri; Yagahira E Castro-Sesquen; Manuela Verastegui; Noelia Angulo; Fernando Recuenco; Ines Cabello; Edith Malaga; Caryn Bern; Cesar M Gavidia; Robert H Gilman
Journal:  Am J Trop Med Hyg       Date:  2016-02-29       Impact factor: 2.345

4.  Retracing micro-epidemics of Chagas disease using epicenter regression.

Authors:  Michael Z Levy; Dylan S Small; Daril A Vilhena; Natalie M Bowman; Vivian Kawai; Juan G Cornejo del Carpio; Eleazar Cordova-Benzaquen; Robert H Gilman; Caryn Bern; Joshua B Plotkin
Journal:  PLoS Comput Biol       Date:  2011-09-15       Impact factor: 4.475

5.  Combined treatment of heterocyclic analogues and benznidazole upon Trypanosoma cruzi in vivo.

Authors:  Denise da Gama Jaén Batista; Marcos Meuser Batista; Gabriel Melo de Oliveira; Constança Carvalho Britto; Ana Carolina Mondaine Rodrigues; Chad E Stephens; David W Boykin; Maria de Nazaré Correia Soeiro
Journal:  PLoS One       Date:  2011-07-26       Impact factor: 3.240

6.  Different infective forms trigger distinct immune response in experimental Chagas disease.

Authors:  Paula Melo de Abreu Vieira; Amanda Fortes Francisco; Evandro Marques de Meneses Machado; Nívia Carolina Nogueira; Kátia da Silva Fonseca; Alexandre Barbosa Reis; Andrea Teixeira-Carvalho; Olindo Assis Martins-Filho; Washington Luiz Tafuri; Cláudia Martins Carneiro
Journal:  PLoS One       Date:  2012-03-07       Impact factor: 3.240

7.  In situ expression of regulatory cytokines by heart inflammatory cells in Chagas' disease patients with heart failure.

Authors:  Denise Bertulucci Rocha Rodrigues; Marlene Antonia dos Reis; Audrey Romano; Sanívia Aparecida de Lima Pereira; Vicente de Paula Antunes Teixeira; Sebastião Tostes; Virmondes Rodrigues
Journal:  Clin Dev Immunol       Date:  2012-07-03

8.  Renovascular hypertension increases serum TNF and CX3CL1 in experimental Trypanosoma cruzi infection.

Authors:  M C Silva; M A Azevedo; V P Figueiredo; M R Moura Junior; D Coelho Junior; P M Martinelli; R P Machado; A C Alzamora; A Talvani
Journal:  Braz J Med Biol Res       Date:  2018-03-26       Impact factor: 2.590

9.  Exacerbated skeletal muscle inflammation and calcification in the acute phase of infection by Mexican Trypanosoma cruzi DTUI strain.

Authors:  Andrea Vizcaíno-Castillo; Andrea Jiménez-Marín; Bertha Espinoza
Journal:  Biomed Res Int       Date:  2014-06-02       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.